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The Institute of Medicine report From Cancer Patient to Cancer Survivor has drawn 
widespread attention to the experiences of cancer survivors. Research examining the 
symptom experiences of survivors are proliferative within the literature but limited by 
samples which include multiple tumour groups and varying inclusion criteria. This cross-
sectional quantitative study seeks to examine pain and quality of life (QoL) in the context of 
colorectal cancer (CRC) survivorship, as defined by the Institute of Medicine. 
Materials and Methods:  
A purposive sample of CRC survivors (n=252) attending hospitals and cancer support 
centres in the Republic of Ireland were recruited between September 2014 and January 
2016. Self-rated health (SRH), QoL and pain were assessed in the sample using the EuroQOL 
questionnaire, the Functional Assessment of Therapy–Colorectal (FACT-C) questionnaire, 
and symptom experience items.  
Results:  
One hundred participants (39.7%) indicated they had pain on the day of the survey or in the 
past week. Of those with pain, many also experienced a lack of energy (94.9%), bowel 
dysfunction (74%), sleep disturbance (76.3%) or interference with their ability to enjoy life 
(74.5%). Pain was associated with younger age, female gender, current chemotherapy 
treatment, and previous radiotherapy treatment. Although participants reported positive 
QoL scores, statistical analysis revealed pain was linked to significantly poorer SRH and 
overall QoL, and poorer physical, emotional, functional, social/family and CRC-specific well-




Pain was experienced by almost two-fifths of CRC survivors up to five years after treatment 
and was associated with poorer SRH and QOL. In light of these findings, healthcare 
professionals must endeavour to manage cancer survivors’ symptom needs in a holistic 






Pain is a complex, multifactorial phenomenon which impacts physical, psychological and 
social domains of living [1]. Modern evolution of cancer treatments means many cancer 
patients may look forward to long-term cancer survivorship, as cancer is managed as a 
chronic illness. However, growing rates of cancer survivorship bring new concerns, as 
chronic effects of cancer treatment gain prominence. A growing discourse surrounding the 
unmet needs of cancer survivors’ has emerged since the publication of From Cancer Patient 
to Cancer Survivor: Lost in Transition [2] a decade ago.  
Previous studies concluded that CRC survivors regain quality of life (QoL) of similar or 
greater levels than those reported by normative populations [3-5]. The positive reframing 
of QoL in the presence of chronic symptoms is a widely discussed and accepted concept 
within the chronic illness literature [3, 6]. However, it is estimated one-third of cancer 
survivors experience pain following curative cancer treatment [5, 7-11], compared to 
almost two-thirds of those receiving anticancer treatment, or living with advanced 
metastatic or terminal cancer [7]. Pain is ranked as a one of the most common symptoms 
experienced by cancer survivors [4, 9, 10], and has been associated with poorer physical 
[12] functional [11-14], psychological [14, 15] and overall [16] QoL, and may contribute to 
social isolation in survivorship [17]. 
Several factors have demonstrated an influence on the presence and intensity of pain 
including age [9, 13, 18], female gender [10, 11, 13, 14, 16, 18], ethnicity [13, 14], symptom 
clusters [13], previous chemotherapy treatment [13, 18], previous radiotherapy treatment 
[18], time since treatment [13, 16], stage of disease [19], and income [11]. Furthermore, 
pain has been shown to occur in clusters with fatigue, insomnia [19], depression [8, 11] and 
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anxiety [11]. The influence of age on pain is the subject of debate. Although almost one-
third cancer survivors report pain [5, 7-11], approximately one-tenth of older CRC survivors 
attribute pain to cancer-related factors [9], compared to almost two-fifths of general CRC 
survivor samples [11]. Studies have revealed older cancer survivors are reluctant to 
attribute symptoms of pain, fatigue or cognitive dysfunction to cancer [17], while age-
related factors have greater predictive ability than cancer-related factors for symptoms of 
pain, low energy levels and weakness [13]. Previous research suggests that ageing does not 
influence increased risk for pain, fatigue or insomnia in elderly cancer survivors [19]; 
however, no consensus has been reached regarding the intensity or frequency of pain flares 
[15, 18]. 
Although under-treatment of pain during cancer treatment has reduced over the past 
decade [20], the prevalence of pain and its impact on CRC survivors’ QoL in the survivorship 
period remains poorly evaluated. Many studies of cancer survivors’ pain focus on samples 
which include multiple tumour groups and varying inclusion criteria [8, 9, 13-15], resulting 
in small samples of each tumour group or a lack of analysis of data pertaining to particular 
tumour groups. Meanwhile studies which evaluate the pain of colorectal cancer (CRC) 
survivors’ have limited generalisability and scope due to small samples sizes [11, 16], lack of 
clear definition of cancer survivorship [15], or sampling of older [12, 19], early stage (<2 
years) [18, 19] or long-term cancer survivors (>5 years) [12]. Therefore the present study 
sought to explore the prevalence and experience of pain in a sample of CRC survivors up to 




Material and Methods:  
Participant Selection: 
The current study is part of a larger mixed-methods study to examine CRC survivors’ QoL 
and healthcare experiences. This report details the results of the cross-sectional survey of 
CRC survivors attending three hospitals and twenty-one cancer support centres for routine 
follow-up care in the Republic of Ireland. All adult CRC survivors who were between 6 
months and five years post-diagnosis, over the age of eighteen years, resident in the 
Republic of Ireland, able to speak, read and comprehend English and able to provide 
informed consent were eligible to participate in the study. In keeping with the Institute of 
Medicine [2] definition of cancer survivorship, CRC survivors were considered eligible for 
participation in the study regardless of their disease status. To minimise the effect of acute 
toxicities on the study findings, CRC survivors were excluded if they were receiving primary 
cancer treatment, or less than six months post-diagnosis. Ethical approval for this study was 
granted by the Research Ethics Committees of the participating hospitals and university. 
Data Collection 
Cancer-related QoL in the seven days preceding the study was measured using the 36-item 
Functional Assessment of Cancer Therapy-Colorectal Cancer (FACT-C) questionnaire [21]. 
The questionnaire contains four subscales of the core FACT-General (FACT-G) 
questionnaire, physical well-being, social well-being, emotional well-being, and functional 
well-being, and colorectal cancer subscale. FACT-C items are assessed using a Likert-scale 
format, with item scores ranging from 0, “not at all” to 4, “very much”, higher scores on 
each subscale reflect better QoL.  
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Cancer survivors’ self-rated health (SRH) was assessed using the five-item EuroQOL EQ-5D-
5L questionnaire and visual analogue scale which measures SRH on the day of the survey on 
a scale of 0-100 [22]. Each health dimension of the EuroQOL questionnaire (Mobility, Self-
Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression) is measured on a five level 
Likert scale, ranging from 0, “no problem,” to 4, “extreme problems”. Both the EuroQOL 
and the FACT-C questionnaires are widely used and have demonstrated validity and 
reliability with CRC populations. 
The presence and intensity of pain was assessed 1) on the day of the survey using the 
EuroQOL item “Pain/Discomfort,” and 2) in the week prior to the survey using the FACT-C 
item “in the past 7 days, I have pain”. Each item was rated on a five-point Likert scale, with 
higher scores reflecting greater pain. Clinical and demographics characteristics assessed in 
the questionnaire included diagnosis, previous and current treatments, time since 
diagnosis, age, gender, living arrangements, employment status, ethnicity and healthcare 
insurance status.  
All eligible CRC survivors identified by gatekeepers during the study period between 
October 2014 and January 2016 were offered written study information and invited to 
participate. Consenting participants were invited to complete an online or paper-based 
survey. Reminder letters were sent to those who had not returned a completed 
questionnaire after four weeks.  
Data Analysis 
For the purpose of analysis, participants who had missing responses to the EuroQOL and 
FACT-C pain items were excluded. Incomplete data from the FACT-C and EuroQOL 
questionnaires were recorded as missing and excluded from relevant analysis. Responses to 
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the EuroQOL and FACT-C pain items were collapsed into binary items, a pain score of 0 was 
coded as “no pain”, while scores ranging between 1-4 were coded as “any pain” in the 
corresponding binary items “pain today” (EuroQOL) or “pain in the past week” (FACT-C). 
Data was analysed using SPSS v21. Cronbach’s α was used to assess the internal consistency 
of the FACT-C scale and subscales. Descriptive statistics were used to characterise the 
demographic and cancer-related attributes of the sample. The prevalence of pain within 
the sample are reported using proportions. QoL and pain intensity scores are reported 
using descriptive measures of centre and spread. Interval estimates of the proportion of the 
population experiencing pain and population mean scores for QoL and SRH are reported 
using 95% confidence intervals. 
The relationship between pain and demographic and medical characteristics were 
examined using Chi-square analysis. Where significant values were recorded, odds ratios 
were calculated using a standardised formula (Table 3). The results of t-tests to examine 
differences in SRH and QoL between groups with and without pain on the day of the survey 
are reported, and Spearman’s Rank Order Correlations were calculated to estimate the 
relationship between pain and QoL. All analysis were undertaken at the level α≤0.05 level 
of significance unless otherwise stated. 
Results:  
Sample Characteristics 
Of the four hundred and four CRC survivors screened and eligible for the study, three 
hundred and four provided informed consent and returned a completed questionnaire (raw 
response rate: 75.2%). Fifty-two participants failed to complete one or both of the EuroQOL 
and FACT-C pain items and were therefore excluded. A final sample of two hundred and 
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fifty-two CRC survivors were included (response rate: 62.3%). Cronbach alpha results for 
the FACT-C subscales were acceptable at α≥0.743, and for the FACT-G and FACT-C scales at 
α=0.94. 
The demographic characteristics and the clinical characteristics of the sample are presented 
in Table 1. The mean age of participants was 66.4 years (SD=11.4). The average time since 
diagnosis for the sample was 3.0 years (SD=1.4) Fifty-five percent were male, eighty percent 
lived with family or friends and more than half had private health insurance (50.2%) or a 
medical card (57.1%), which allows the holder to receive healthcare free of charge or at a 
discounted rate in the public healthcare system. Almost half of participants were retired 
(47.7%).  
Pain 
Frequencies and mean pain ratings reported by the participants’ are reported in Table 2. On 
the day of the survey, ninety participants (35.7%, CI: 29.8%-41.6%) reported pain, while 
seventy-seven participants had experienced pain in the seven days prior to the study 
(30.6%, CI: 24.9%-36.3%). The low mean pain scores reported by the sample on the day of 
the survey (?̅?=0.47, SD=0.72) and in the week prior to the survey (?̅?=0.46, SD=0.81) are 
reflective of the large proportions reporting no pain or low-moderate levels of pain.  
Overall, 39.7% (n=100) reported pain at one or both time points. Figure 1 presents the 
frequency of the most commonly reported symptoms experienced by CRC survivors who 
had any pain. Compared to participants who did not experience pain, those with pain were 
more likely to report a lack of energy (p≤0.0005, OR=17.84), body image disturbance 
(p=0.002, OR=2.76), or an inability to work (p≤0.0005, OR=5.58). High proportions of those 
with pain indicated challenges with enjoyment of hobbies (78.8%, n=78), ability to work 
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(79.4%, n=77) and enjoyment of life (74.5%, n=73). 74.5% of participants with pain were 
discontent with their QoL, compared to 32% of those with no pain. A greater proportion of 
CRC survivors with pain were more likely to indicate problems with all FACT-C and symptom 
items (p≤0.05) with six exceptions; feeling close to one’s partner (p=0.236), satisfaction 
with one’s sex life (p=0.178), difficulty urinating (p=0.068), urinary frequency (p=0.118), 
fear of cancer recurrence (p=0.269) and fear of cancer spread (p=0.078). 
Table 3 presents the results of Chi-square analysis to determine differences between CRC 
survivors’ based on demographic and medical characteristics. Younger age (p=0.003, 
OR=2.271), receipt of current anti-cancer treatment (p=0.002, OR=3.494), previous 
chemotherapy treatment (p≤0.0005, OR=3.639) and previous radiotherapy treatment 
(p=0.006, OR =2.241) were each significantly associated with cancer survivors experience of 
pain on the day of the survey. Likewise, younger age (p=0.027, OR=1.822), receipt of 
current anti-cancer treatment (p=0.001, OR=3.969) and previous chemotherapy treatment 
(p=0.001, OR=2.806) were significantly associated with cancer survivors experience of pain 
during the week prior to the survey. 
Quality of Life 
Table 4 presents results of descriptive and inferential analysis of QOL and SRH for the 
sample based on pain experience. The sample reported positive perceptions of their health 
(?̅?=81.4, SD =16.2) and CRC-related QoL (FACT-C: ?̅?=111.9, SD=18.9). CRC survivors who 
reported pain on the day of the survey and in the week preceding the survey reported 
significantly poorer SRH and QoL scores on all scales (p≤0.05). The results of correlation 
analysis between pain and QoL indicators are presented in Table 5. Increasing pain today or 
in the past week was negatively associated with SRH and QoL on all subscales (p≤0.05). The 
relationships between pain today or in the past week and QoL were moderate for all 
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subscales with two exceptions. Physical well-being had a strong correlation with pain on the 
day of the survey (𝑟𝑠=-0.653) and in the past week (𝑟𝑠=-0.691). Social well-being had a weak 
correlation with pain on the day of the survey (𝑟𝑠=-0.281) and in the past week (𝑟𝑠=-0.293). 
Discussion: 
This study sought to explore the prevalence and experience of pain in a sample of CRC 
survivors up to five years following diagnosis and the effect of pain on CRC survivors’ QoL. 
Two-fifths of the sample reported pain on the day of the survey or in the past week. When 
the groups were compared based on the demographic and medical variables under study, 
CRC survivors who reported pain today and pain in the last week were more likely to be 
younger, receiving current anti-cancer treatment and have previous chemotherapy 
treatment. Previous radiotherapy treatment was associated with experience of pain on the 
day of the survey only. CRC survivors who reported pain on the day of the survey or the 
week preceding participation in the survey indicated significantly poorer SRH, lower overall 
QoL scores, worse physical, social, emotional and functional well-being and a greater 
degree of CRC-specific QoL concerns compared to CRC survivors who did not report pain. 
The prevalence of pain in this sample of CRC survivors mirror the findings of previous 
research of cancer survivors which include multiple tumour groups [5, 7-11], albeit slightly 
higher than the prevalence reported in CRC survivor samples of other studies [5, 9]. 
However, the finding that gender and time since diagnosis are not associated with CRC 
survivors’ experience of pain refutes the findings of several studies [10, 11, 13, 14, 16, 18]. 
These differences may be attributed to differences in study designs, as studies of CRC 
survivors tend to have had smaller samples, and may be at risk of type I errors [10, 11, 16], 
while others examined short-term [18], long-term [13] and diverse groups of cancer 
survivors [13, 14]. 
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The impact of age on cancer survivors’ experiences of pain is debatable. The nature of CRC 
means the profile of survivors is skewed to middle-older age males and females. This study 
has found younger cancer survivors were twice as likely as older cancer survivors to report 
pain on the day of the survey and in the week preceding the survey. Previous studies have 
reported older cancer survivors have expressed difficulty in ascribing pain and other 
symptoms to cancer-related or age-related factors [9, 11, 17], while poorer QoL and greater 
symptom burden in younger cancer survivors have been attributed to fewer coping 
strategies and greater perceived threat of recurrence [4, 6]. To understand this finding, it is 
not unreasonable to hypothesise that younger age, and fewer comorbidities may permit 
more aggressive treatment strategies, contributing to a higher rate of late toxicities [6]. This 
is tentatively supported by the findings of the current study which associate previous 
radiotherapy and current chemotherapy with a greater likelihood of experiencing pain. 
Furthermore, younger CRC survivors may also experience a greater disturbance in their 
work life arising from chronic effects. This study showed that those who experience pain 
were more likely to indicate they were unable to work or gain fulfilment from their work 
compared to those who did not experience pain. 
Although the mean QoL scores reported within this study are comparable to population 
norms [3-5], pain was significantly associated with poorer SRH and QoL on all subscales. 
Furthermore, differences in FACT-C scores between those who did and did not report pain 
are clinically significant, with disparities greater than the minimally important differences 
suggested by Yost and colleagues [23]. In addition, almost 95% of those who reported pain 
also experienced a lack of energy in the week preceding the survey, this is comparable to 
previous studies [13]. Pain and fatigue are potential deterrents to activity and have 
implications for the psychological well-being of the cancer survivor. Pain and fatigue may 
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signify potential recurrence or disease progression [24, 25], while late-effects of cancer may 
also contribute to social withdrawal, functional disability, resentment and anger in the long-
term [17].  
Strengths/Limitations 
The results must be interpreted with cognisance of study limitations. Although this sample 
was drawn from multiple research sites serving various socio-economic groups, the cross-
sectional nature presents a limitation to the generalisability of this study. Furthermore, the 
questionnaire items used to assess pain in this sample limit this study, as they are not 
considered profound measures of pain. However, they are drawn from instruments which 
have established validity and reliability for CRC survivor populations. Moreover, the 
measures provide suitable means to assess point prevalence of pain, consistent with prior 
research and within the objectives of this study.  
This study has addressed many of the previously discussed limitations of cancer 
survivorship research including clarity of disease status, definition of survivorship and 
purposive sampling strategies [11]. The strong response rate of 62.3% and rigour of 
inclusion criteria are strengths of this study. The sample is representative of CRC survivors 
in Ireland, as participants were recruited from routine follow-up care in hospitals and 
support centers which reflect the variety of settings in which CRC follow-up care is 
delivered in Ireland. The inclusion criteria ensure that the sample is consistent with the 
definition of survivorship set forth by the Institute of Medicine [2], and the symptoms 
reported are not contaminated by acute consequences of treatment. The homogenous 
sample of CRC survivors ensure the results are generalisable to similar populations of CRC 
survivors, and not biased by issues pursuant to other cancer survivor groups. The findings of 
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this study add to the limited knowledge available regarding CRC survivors’ experience of 
pain and its impact on QoL.  
These findings present a basis to direct larger-scale epidemiological research of QoL and 
symptom prevalence among CRC survivors. The results of this work guide the development 
of a qualitative research approach within an ongoing body of mixed-methods research. The 
qualitative component of this study provides an opportunity to fully evaluate CRC survivors’ 
symptom experiences, providing depth, context and coherence to the picture painted by 
these results. 
Conclusion 
The findings of this study add to the growing evidence base surrounding symptom burden 
and management in CRC survivors. The high prevalence of symptoms which co-occur with 
pain and the association between pain and poorer QoL is a cause for concern, and one 
which healthcare professionals must remain cognisant. It is not enough to assess and 
manage CRC survivors’ pain in isolation. Indeed, considering pain within the bigger picture 
of survivors’ comorbidities and cancer-related complaints is imperative to address their 
needs holistically. Such an approach will ensure healthcare professionals may develop 
appropriate pain management strategies which will assist CRC survivors to sustain 
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